![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada
Phosphoinositide 3-kinase (PI3K) may potentially influence intracellular [Ca2+]i concentration by several mechanisms. We have investigated the effects of phosphoinositide 3-kinase (PI3K) inhibitors wortmannin and LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] on Ca2+ signaling in rat airway smooth muscle (ASM) cells using fura-2 and imaging methodology. Wortmannin (1 µM) and LY-294002 (1 and 10 µM) had opposite effects: wortmannin caused a small increase, whereas LY-294002 caused a significant decrease of peak Ca2+ responses to serotonin (5-HT). LY-294002 (10 µM) diminished 5-HT-induced ASM cell contraction, measured as a change in cell surface area, and inositol phosphate formation, measured by anion exchange chromatography. Thin layer chromatography revealed that the levels of phospholipase C (PLC) substrate phosphatidylinositol 4,5-bisphosphate were not affected. SDS polyacrylamide gel electrophoresis and Western blotting have shown that both wortmannin and LY-294002 inhibited platelet-derived growth factor-induced PI3K activation. However, PI3K activation could not be detected after 5-HT stimulation. The specific casein kinase-2 (CK2) inhibitor 5,6-dichloro-1-
-D-ribofuranosyl-benzimidazole (10-40 µM) reduced 5-HT-triggered responses to a similar extent as LY-294002. We conclude that LY-294002 modulates Ca2+ signaling in rat ASM independently of its action on PI3K by acting on, or upstream of, PLC, possibly by inhibiting CK2.
Address correspondence to: Dr. James G. Martin, Meakins-Christie Laboratories, McGill University, 3626 St-Urbain St., Montreal, Quebec, Canada H2 2P2. E-mail: james.martin{at}mcgill.ca
This article has been cited by other articles:
![]() |
X. Yin, B. Li, H. Chen, and K. J. Catt Differential Signaling Pathways in Angiotensin II- and Epidermal Growth Factor-stimulated Hepatic C9 Cells Mol. Pharmacol., November 1, 2008; 74(5): 1223 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kwintkiewicz, Z. Cai, and C. Stocco Follicle-Stimulating Hormone-Induced Activation of Gata4 Contributes in the Up-Regulation of Cyp19 Expression in Rat Granulosa Cells Mol. Endocrinol., April 1, 2007; 21(4): 933 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Azam, K. Yoshioka, S. Ohkura, N. Takuwa, N. Sugimoto, K. Sato, and Y. Takuwa Ca2+-Independent, Inhibitory Effects of Cyclic Adenosine 5'-Monophosphate on Ca2+ Regulation of Phosphoinositide 3-Kinase C2{alpha}, Rho, and Myosin Phosphatase in Vascular Smooth Muscle J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamaguchi, S.-H. Lee, J.-S. Kim, J. Wimalasena, S. Kitajima, and S. J. Baek Activating Transcription Factor 3 and Early Growth Response 1 Are the Novel Targets of LY294002 in a Phosphatidylinositol 3-Kinase-Independent Pathway Cancer Res., February 15, 2006; 66(4): 2376 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Brown, M. D. Hollenberg, and C. A. Jones Tryptase activates phosphatidylinositol 3-kinases proteolytically independently from proteinase-activated receptor-2 in cultured dog airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L259 - L269. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beloueche-Babari, L. E. Jackson, N. M.S. Al-Saffar, S. A. Eccles, F. I. Raynaud, P. Workman, M. O. Leach, and S. M. Ronen Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells Mol. Cancer Ther., January 1, 2006; 5(1): 187 - 196. [Abstract] [Full Text] [PDF] |
||||